COSCIENS Biopharma Inc.
CSCIF
$4.98
-$0.32-6.04%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -202.00K | 10.76M | -2.18M | -1.82M | -2.70M |
| Total Depreciation and Amortization | 337.00K | 341.00K | 289.00K | 287.00K | 287.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 681.00K | -11.86M | -15.00K | -95.00K | 392.00K |
| Change in Net Operating Assets | -217.00K | -1.42M | 439.00K | 951.00K | -2.43M |
| Cash from Operations | 599.00K | -2.18M | -1.47M | -676.00K | -4.45M |
| Capital Expenditure | -8.00K | -2.00K | -46.00K | -- | -49.00K |
| Sale of Property, Plant, and Equipment | 7.00K | 9.00K | 239.00K | 4.00K | 1.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -30.00K | -- | -- | -- |
| Other Investing Activities | -205.00K | -- | 8.00K | -- | -- |
| Cash from Investing | -206.00K | -23.00K | 201.00K | 4.00K | -48.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -58.00K | -82.00K | -15.00K | -85.00K | -65.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -- | -42.00K |
| Cash from Financing | -58.00K | -82.00K | -15.00K | -85.00K | -107.00K |
| Foreign Exchange rate Adjustments | -62.00K | -20.00K | 67.00K | -52.00K | 177.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 273.00K | -2.30M | -1.22M | -809.00K | -4.43M |